Patents by Inventor Ernest Bueding

Ernest Bueding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of reducing or avoiding the mutagenic activity of drugs
    Patent number: 4328215
    Abstract: A method for reducing or avoiding the transformation of a drug into a mutagenic metabolite in a host to whom the drug is administered, the method comprising administering an antibacterial agent to the host in conjunction with the administration of the drug.
    Type: Grant
    Filed: May 9, 1977
    Date of Patent: May 4, 1982
    Assignee: The Johns Hopkins University
    Inventor: Ernest Bueding
  • 2-Chloro-4-(4-lower alkyl-1-piperazinyl)benzenemethanol, N.sup..omega. -oxides and methods for their preparation
    Patent number: 4234583
    Abstract: 2-Chloro-4-(4-lower alkyl-1-piperazinyl)benzenemethanol, N.sup..omega. -oxides and their acid addition salts. These compounds are prepared by oxidizing the corresponding 2-chloro-4-(4-lower alkyl-1-piperazinyl)benzenemethanol. In addition, pharmaceutical compositions comprising said N-oxides and methods for treating schistosomiasis are disclosed.
    Type: Grant
    Filed: November 30, 1978
    Date of Patent: November 18, 1980
    Assignee: Edna McConnell Clark Foundation
    Inventors: Ernest Bueding, Leslie M. Werbel, Donald F. Worth